Bausch + Lomb Corporation
NYSE:BLCOMedical - Instruments & Supplies
+$0.04 today
- Market cap
- $7.49B
- Beta
- 0.57
- P/E (TTM)
- -24.2
- EPS (TTM)
- -$0.62
Volume 0.51M
Average 0.46M
BLCO EBITDA Margin
EBITDA as a percentage of revenue.
Bausch + Lomb CorporationNYSE: BLCO
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin widens to 13.2%
EBITDA Margin was 13.2% in Q2 FY2026, up 6.1 pp from a year earlier. On a trailing-twelve-month basis it was 13.9%, up 4.5 pp year over year. Over 3 fiscal years it narrowed by 5.4 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 11 analysts of 22.2% for the fiscal year ending Dec 2026, up from 10.5% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 13.2%+2.2 pp QoQ
- Last fiscal yearDec 2025
- 10.5%-2.1 pp YoY
- LTMJun 2026
- 13.9%+4.5 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +6.1 pp | +5.7 pp | -0.5 pp |
| 1 year | -2.1 pp | +11.8 pp | +13.8 pp |
| 3 years | -5.4 pp | +14.3 pp | +19.6 pp |
| 5 years | +18.0 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 10.5%
- Year-over-year change
- -2.1pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.5% | -2.1pp |
| FY2024 | 2024-12-31 | 12.5% | +0.5pp |
| FY2023 | 2023-12-31 | 12.0% | -3.8pp |
| FY2022 | 2022-12-31 | 15.9% | -3.6pp |
| FY2021 | 2021-12-31 | 19.5% | — |
EBITDA Margin vs competitors
How BLCO compares with its peers on the latest reported figures
- BLCO's LTM Jun 2026 EBITDA Margin of 13.9% is the 4th highest of the 9 companies compared; the peer median is -1.0%.
- Its year-over-year change of +4.5 pp is the 2nd highest of 9, against a peer median of -18.9 pp.
- Over three fiscal years its change of -5.4 pp compares with a peer median of +8.4 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 21.3% | -0.4 pp | +7673.7 pp | |
| LTM Sep 2026 | 21.2% | -0.0 pp | +6.2 pp | |
| LTM Jun 2026 | 17.2% | -30.5 pp | +103.9 pp | |
| LTM Jun 2026 | 13.9% | +4.5 pp | -5.4 pp | |
| LTM Jun 2026 | 4.1% | +5.0 pp | +10.5 pp | |
| LTM Jun 2026 | -6.1% | -25.9 pp | -11.0 pp | |
| LTM Jun 2026 | -23.0% | -12.0 pp | -11.5 pp | |
| LTM Sep 2026 | -133.9% | -153.8 pp | -60.9 pp | |
| LTM Sep 2026 | -1917.5% | -679.9 pp | +127741.9 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding BLCO) | -1.0% | -18.9 pp | +8.4 pp | |
Competitors are the stored peer set for BLCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.77B | 3.77B | 4.15B | 4.79B | 5.1B |
| Cost of Revenue | 1.47B | 1.52B | 1.64B | 1.87B | 2.31B |
| Gross Profit | 2.3B | 2.25B | 2.5B | 2.92B | 2.79B |
| Gross Margin | 61.0% | 59.7% | 60.4% | 60.9% | 54.8% |
| Research & Development | 271M | 307M | 324M | 343M | 371M |
| Selling, General & Admin | 1.39B | 1.48B | 1.74B | 2.08B | 2.23B |
| Operating Expenses | 1.97B | 2.04B | 2.37B | 2.76B | 2.61B |
| Depreciation & Amortization | 415M | 379M | 382M | 436M | 421M |
| EBITDA | 733M | 598M | 499M | 601M | 535M |
| EBITDA Margin | 19.5% | 15.9% | 12.0% | 12.5% | 10.5% |
| Operating Income | 329M | 207M | 130M | 162M | 188M |
| Operating Margin | 8.7% | 5.5% | 3.1% | 3.4% | 3.7% |
| Interest Income | 0 | 6M | 15M | 15M | 12M |
| Interest Expense | 0 | 146M | 283M | 399M | 431M |
| Other Income / Expenses | (11M) | (134M) | (296M) | (396M) | (505M) |
| Income Before Tax | 318M | 73M | (166M) | (234M) | (317M) |
| Pre-Tax Margin | 8.4% | 1.9% | -4.0% | -4.9% | -6.2% |
| Income Tax Expense | 125M | 58M | 82M | 71M | 35M |
| Net Income | 182M | 6M | (260M) | (317M) | (360M) |
| Net Margin | 4.8% | 0.2% | -6.3% | -6.6% | -7.1% |
| EPS (Basic) | 0.52 | 0.04 | (0.74) | (0.90) | (1.02) |
| EPS (Diluted) | 0.52 | 0.04 | (0.74) | (0.90) | (1.02) |
| Weighted Avg Shares | 350M | 350M | 350.5M | 351.8M | 353.8M |
| Weighted Avg Shares (Diluted) | 350M | 350M | 350.5M | 351.8M | 353.8M |
Bausch + Lomb Corporation
NYSE:BLCO
Intrinsic Alpha fair value
Locked
Current Price
$20.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.